1. Primary afferent nerve fibers control cutaneous blood flow and vasc
ular permeability by releasing vasoactive peptides. These vascular rea
ctions and the additional recruitment of leukocytes are commonly embod
ied in the term neurogenic inflammation. 2. Calcitonin gene-related pe
ptide (CGRP) acting via CGRP(1) receptors is the principal transmitter
of neurogenic dilatation of arterioles whereas substance P (SP) and n
eurokinin A (NKA) acting via NK1 receptors mediate the increase in ven
ular permeability. 3. Neurogenic vasodilatation and plasma protein lea
kage play a role in inflammation because many inflammatory and immune
mediators including interleukin-1 beta, nitric oxide, prostanoids, pro
tons, bradykinin, histamine, and 5-hydroxytryptamine can stimulate pep
tidergic afferent nerve fibers or enhance their excitability, 4. Neuro
genic inflammatory reactions can be suppressed by alpha(2)-adrenocepto
r agonists, histamine acting via H-3 receptors, 5-hydroxytryptamine ac
ting via 5-HT1B receptors, opioid peptides, and somato statin through
prejunctional inhibition of peptide release from vasoactive afferent n
erve fibers. CGRP, SP, and NKA receptor antagonists are powerful pharm
acological tools to inhibit neurogenic inflammation at the postjunctio
nal level. 5. Imbalance between the facilitatory and inhibitory influe
nces on afferent nerve activity has a bearing on chronic inflammatory
disease. Impaired nerve function represents a deficit in skin homeosta
sis while neuronal overactivity is a factor in allergic and hyperreac
tive disorders of the skin. (C) 1998 Elsevier Science Inc.